
INDAPTUS THERAPEUTICS INC
INDP · NASDAQ
Updated at 2026-10-15 08:59:10
- Today's High
- $2.40
- Today’s Low
- $2.02
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $2.34
- Previous Close
- $2.21
- Volume
- 450.02K
- Market Cap
- $339.41M
- P/E Ratio
- --
- EPS
- $-7.74
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- THREE COLUMBUS CIRCLE, NEW YORK, NY, UNITED STATES, 10019
- Country
- US
- Listing Date
- 2012-09-07
- Fiscal Year End
- December
- Shares Outstanding
- 113.24M
- CIK
- 0001857044
- Website
- indaptusrx.com
Indaptus Therapeutics Inc. is a pioneering biotechnology firm focused on advancing immunotherapies that aim to transform cancer treatment paradigms. Utilizing its proprietary platform, the company enhances the immune system's capacity to identify and eliminate tumor cells, thereby improving therapeutic efficacy and patient outcomes. With a robust pipeline of clinical candidates aimed at addressing critical unmet needs in oncology, Indaptus is strategically positioned for growth in a competitive market. By fostering collaborations with leading research institutions and a commitment to scientific innovation, Indaptus aspires to emerge as a key player in the biopharmaceutical sector.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$1.8M
2026-03-31
$2.15M
2025-12-31
$8.15M
2025-09-30
$2.64M
Net Income
2026-06-30
-$1.79M
2026-03-31
-$2.54M
2025-12-31
-$8.11M
2025-09-30
-$2.97M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.02
2026-03-31
--
2025-12-31
$-9.19
2025-09-30
$-2.98
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$1.82M
2026-03-31
-$2.54M
2025-12-31
-$8.11M
2025-09-30
-$2.97M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $1.8M | $2.15M | $8.15M | $2.64M |
| Net Income | -$1.79M | -$2.54M | -$8.11M | -$2.97M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.02 | -- | $-9.19 | $-2.98 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$1.82M | -$2.54M | -$8.11M | -$2.97M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.